Serum microRNA-210 as a predictive biomarker for treatment response and prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 8, 2014, Pages 1279-1287.e1

  Zhan, Meixiao ^a   Li, Yong ^a   Hu, Baoshan ^a   He, Xu ^a   Huang, Jianwen ^a   Zhao, Yan ^a   Fu, Sirui ^a   Lu, Ligong ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; MICRORNA 210; TUMOR MARKER; MICRORNA; MIRN210 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BARCELONA CLINIC LIVER CANCER STAGE; BLOOD LEVEL; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; EVALUATION STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MODIFIED RESPONSE EVALUATION CRITERIA IN SOLID TUMORS ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PRIORITY JOURNAL; SOLID TUMOR; SURVIVAL RATE; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; TUMOR VOLUME; ADVERSE EFFECTS; BLOOD; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; DISEASE COURSE; GENETICS; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; TUMOR INVASION; UPREGULATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE PROGRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84905220431     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2014.04.013     Document Type: Article

References (26)

1. J.M. Llovet, M.I. Real, and X. Montana et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
2. A. Sergio, C. Cristofori, and R. Cardin et al. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness Am J Gastroenterol 103 2008 914 921
3. G.L. Semenza Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 29 2010 625 634
4. R. Kloeckner, G. Otto, S. Biesterfeld, K. Oberholzer, C. Dueber, and M.B. Pitton MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma Cardiovasc Intervent Radiol 33 2010 532 540
5. R. Golfieri, M. Renzulli, and C. Mosconi et al. Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension? J Vasc Interv Radiol 24 2013 509 517
6. J. Lu, G. Getz, and E.A. Miska et al. MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
7. X. Chen, Y. Ba, and L. Ma et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Res 18 2008 997 1006
8. P.S. Mitchell, R.K. Parkin, and E.M. Kroh et al. Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
9. A.J. Schetter, S.Y. Leung, and J.J. Sohn et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma JAMA 299 2008 425 436
10. B. Wang, H. Xu, Z.Q. Gao, H.F. Ning, Y.Q. Sun, and G.W. Cao Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization Acta Radiol 49 2008 523 529
11. Q. Ying, L. Liang, and W. Guo et al. Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma Hepatology 54 2011 2064 2075
12. T. Greither, L.F. Grochola, A. Udelnow, C. Lautenschlager, P. Wurl, and H. Taubert Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival Int J Cancer 126 2010 73 80
13. J. Li, Y. Wang, W. Yu, J. Chen, and J. Luo Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance Biochem Biophys Res Commun 406 2011 70 73
14. A.M. Liu, T.J. Yao, and W. Wang et al. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study BMJ Open 2 2012 e000825
15. Primary Liver Cancer Diagnosis and Treatment Expert Panel of the Chinese Ministry of Health. Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition) Chin Clin Oncol 1 2012 1 32
16. L. Chuan-Xing, H. Xu, and H. Bao-Shan et al. Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed Cancer Biol Ther 12 2011 865 871
17. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
18. A. Zhao, G. Li, M. Peoc'h, C. Genin, and M. Gigante Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma Exp Mol Pathol 94 2013 115 120
19. P. Pineau, S. Volinia, and K. McJunkin et al. miR-221 overexpression contributes to liver tumorigenesis Proc Natl Acad Sci U S A 107 2010 264 269
20. E.J. Jung, L. Santarpia, and J. Kim et al. Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients Cancer 118 2012 2603 2614
21. H.H. Cheng, P.S. Mitchell, and E.M. Kroh et al. Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia PLoS One 8 2013 e69239
22. C.S. Neal, M.Z. Michael, L.H. Rawlings, M.B. Van der Hoek, and J.M. Gleadle The VHL-dependent regulation of microRNAs in renal cancer BMC Med 8 2010 64
23. L. Scapoli, A. Palmieri, and L. Lo Muzio et al. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression Int J Immunopathol Pharmacol 23 2010 1229 1234
24. E.S. Jung, J.H. Kim, and E.L. Yoon et al. Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization J Hepatol 58 2013 1181 1187
25. S.J. Cho, J.H. Yoon, S.S. Hwang, and H.S. Lee Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol 22 2007 1226 1231
26. C.Y. Hong, X. Chen, J. Li, J.H. Chen, G. Chen, and H.H. Yang Direct detection of circulating microRNAs in serum of cancer patients by coupling protein-facilitated specific enrichment and rolling circle amplification Chem Commun (Camb) 50 2014 3292 3295